Mechanism of PERK - eIF2a Pathways in Intestinal Mucosal Barrier of IBS-D and the Role "Metabolism Ingredients" of Tongxieyaofang
Clinical trial NCT04122586 · UNKNOWN
Trial details
- NCT number
- NCT04122586
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.